These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6096758)

  • 21. Interactions of cholecystokinin and glucose in rat pancreatic islets.
    Zawalich W; Takuwa N; Takuwa Y; Diaz VA; Rasmussen H
    Diabetes; 1987 Apr; 36(4):426-33. PubMed ID: 3028890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Nov; 7(3):243-52. PubMed ID: 6141625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central and peripheral control of postprandial pyloric motility by endogenous opiates and cholecystokinin in dogs.
    Lopez Y; Fioramonti J; Bueno L
    Gastroenterology; 1991 Nov; 101(5):1249-55. PubMed ID: 1936795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
    Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cholecystokinin on the accumulation of inositol phosphates in isolated pancreatic islets.
    Florholmen J; Malm D; Vonen B; Burhol PG
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G865-70. PubMed ID: 2692460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulatory and inhibitory effects of galanin on exocrine and endocrine rat pancreas.
    Rünzi M; Müller MK; Schmid P; von Schönfeld J; Goebell H
    Pancreas; 1992; 7(6):619-23. PubMed ID: 1280360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
    Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
    J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asperlicin antagonizes stimulatory effects of cholecystokinin on isolated islets.
    Zawalich WS; Diaz VA
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E370-4. PubMed ID: 3548432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a role of endogenous opiates in postprandial somatostatin release.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Aug; 6(4):355-61. PubMed ID: 6138819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous opioid modulation of pancreatic hormone secretion: studies in dogs.
    Levin ER; Yamada T; Levin S; Mills S
    Metabolism; 1986 Jan; 35(1):59-63. PubMed ID: 2867455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals.
    Schusdziarra V; Holland A; Maier V; Pfeiffer EF
    Peptides; 1984; 5(1):65-71. PubMed ID: 6143305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cholecystokinin octapeptide and carbachol on neonatal insulin secretory dynamics.
    Fletcher DJ; Rowley WH; Brinn JE
    Regul Pept; 1989; 25(3):287-93. PubMed ID: 2672124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.
    Ahrén B; Lundquist I
    Acta Diabetol Lat; 1981; 18(4):345-56. PubMed ID: 6277122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of galanin(1-16) on pancreatic secretion in anesthetized and conscious rats.
    Takács T; Hegyi P; Czakó L; Baláspiri L; Lonovics J
    Res Exp Med (Berl); 2000 Apr; 199(5):275-83. PubMed ID: 10815756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement.
    Malm D; Giaever A; Vonen B; Florholmen J
    Scand J Clin Lab Invest; 1993 Nov; 53(7):671-6. PubMed ID: 7903820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.